224 related articles for article (PubMed ID: 35640075)
21. CNS complications of breast cancer: current and emerging treatment options.
Kaal EC; Vecht CJ
CNS Drugs; 2007; 21(7):559-79. PubMed ID: 17579499
[TBL] [Abstract][Full Text] [Related]
22. Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery.
Tam M; Narayana A; Raza S; Kunnakkat S; Golfinos JG; Parker EC; Novik Y
Med Oncol; 2014 Feb; 31(2):832. PubMed ID: 24390418
[TBL] [Abstract][Full Text] [Related]
23. Defining prognosis for women with breast cancer and CNS metastases by HER2 status.
Dawood S; Broglio K; Esteva FJ; Ibrahim NK; Kau SW; Islam R; Aldape KD; Yu TK; Hortobagyi GN; Gonzalez-Angulo AM
Ann Oncol; 2008 Jul; 19(7):1242-1248. PubMed ID: 18334512
[TBL] [Abstract][Full Text] [Related]
24. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline.
Gondi V; Bauman G; Bradfield L; Burri SH; Cabrera AR; Cunningham DA; Eaton BR; Hattangadi-Gluth JA; Kim MM; Kotecha R; Kraemer L; Li J; Nagpal S; Rusthoven CG; Suh JH; Tomé WA; Wang TJC; Zimmer AS; Ziu M; Brown PD
Pract Radiat Oncol; 2022; 12(4):265-282. PubMed ID: 35534352
[TBL] [Abstract][Full Text] [Related]
25. Local and systemic therapy in breast cancer patients with central nervous system metastases.
Wellerdieck NEA; Wessels P; Los M; Sonke GS; Tromp E; Brandsma D
Breast Cancer Res Treat; 2022 Jul; 194(2):365-384. PubMed ID: 35680734
[TBL] [Abstract][Full Text] [Related]
26. Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.
Yomo S; Hayashi M; Cho N
J Neurooncol; 2013 Apr; 112(2):199-207. PubMed ID: 23296546
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
Moy B; Rumble RB; Come SE; Davidson NE; Di Leo A; Gralow JR; Hortobagyi GN; Yee D; Smith IE; Chavez-MacGregor M; Nanda R; McArthur HL; Spring L; Reeder-Hayes KE; Ruddy KJ; Unger PS; Vinayak S; Irvin WJ; Armaghani A; Danso MA; Dickson N; Turner SS; Perkins CL; Carey LA
J Clin Oncol; 2021 Dec; 39(35):3938-3958. PubMed ID: 34324366
[TBL] [Abstract][Full Text] [Related]
28. CNS Metastases in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: Impact on Health Resource Utilization.
Chooback N; Lefresne S; Lau SC; Ho C
J Oncol Pract; 2018 Oct; 14(10):e612-e620. PubMed ID: 30216125
[TBL] [Abstract][Full Text] [Related]
29. Brain metastases in breast cancer: analysis of the role of HER2 status and treatment in the outcome of 94 patients.
Fokas E; Henzel M; Hamm K; Grund S; Engenhart-Cabillic R
Tumori; 2012 Nov; 98(6):768-74. PubMed ID: 23389365
[TBL] [Abstract][Full Text] [Related]
30. Metastases to the central nervous system: Molecular basis and clinical considerations.
Wanleenuwat P; Iwanowski P
J Neurol Sci; 2020 May; 412():116755. PubMed ID: 32120132
[TBL] [Abstract][Full Text] [Related]
31. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
Eisen A; Somerfield MR; Accordino MK; Blanchette PS; Clemons MJ; Dhesy-Thind S; Dillmon MS; D'Oronzo S; Fletcher GG; Frank ES; Hallmeyer S; Makhoul I; Moy B; Thawer A; Wu JY; Van Poznak CH
J Clin Oncol; 2022 Mar; 40(7):787-800. PubMed ID: 35041467
[TBL] [Abstract][Full Text] [Related]
32. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
[TBL] [Abstract][Full Text] [Related]
33. Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update Summary.
Ramakrishna N; Temin S; Lin NU
J Oncol Pract; 2018 Aug; 14(8):505-507. PubMed ID: 29989840
[No Abstract] [Full Text] [Related]
34. Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
Kim HJ; Im SA; Keam B; Kim YJ; Han SW; Kim TM; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Noh DY; Heo DS; Park IA; Bang YJ; Ha SW
J Neurooncol; 2012 Jan; 106(2):303-13. PubMed ID: 21938531
[TBL] [Abstract][Full Text] [Related]
35. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
[TBL] [Abstract][Full Text] [Related]
36. Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER-Medicare analysis.
Sadetsky N; Hernandez A; Wallick CJ; McKenna EF; Surinach A; Colburn DE
Cancer Med; 2020 Sep; 9(17):6216-6224. PubMed ID: 32667719
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
[TBL] [Abstract][Full Text] [Related]
38. Molecular subtyping of brain metastases and implications for therapy.
Renfrow JJ; Lesser GJ
Curr Treat Options Oncol; 2013 Dec; 14(4):514-27. PubMed ID: 23907440
[TBL] [Abstract][Full Text] [Related]
39. The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?
Cho E; Rubinstein L; Stevenson P; Gooley T; Philips M; Halasz LM; Gensheimer MF; Linden HM; Rockhill JK; Gadi VK
Breast Cancer Res Treat; 2015 Feb; 149(3):743-9. PubMed ID: 25638395
[TBL] [Abstract][Full Text] [Related]
40. Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.
Olson EM; Abdel-Rasoul M; Maly J; Wu CS; Lin NU; Shapiro CL
Ann Oncol; 2013 Jun; 24(6):1526-33. PubMed ID: 23463626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
